
Bio-Techne Corp
NASDAQ:TECH

Intrinsic Value
The intrinsic value of one
TECH
stock under the Base Case scenario is
49.8
USD.
Compared to the current market price of 49.15 USD,
Bio-Techne Corp
is
Undervalued by 1%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Bio-Techne Corp
Fundamental Analysis


Revenue & Expenses Breakdown
Bio-Techne Corp
Balance Sheet Decomposition
Bio-Techne Corp
Current Assets | 627.2m |
Cash & Short-Term Investments | 140.7m |
Receivables | 237.1m |
Other Current Assets | 249.4m |
Non-Current Assets | 2B |
Long-Term Investments | 254.5m |
PP&E | 335.7m |
Intangibles | 1.4B |
Other Non-Current Assets | 14.5m |
Free Cash Flow Analysis
Bio-Techne Corp
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Bio-Techne Corp
Revenue
|
1.2B
USD
|
Cost of Revenue
|
-406.2m
USD
|
Gross Profit
|
802.5m
USD
|
Operating Expenses
|
-584.3m
USD
|
Operating Income
|
218.2m
USD
|
Other Expenses
|
-86.6m
USD
|
Net Income
|
131.6m
USD
|
TECH Profitability Score
Profitability Due Diligence
Bio-Techne Corp's profitability score is 58/100. The higher the profitability score, the more profitable the company is.

Score
Bio-Techne Corp's profitability score is 58/100. The higher the profitability score, the more profitable the company is.
TECH Solvency Score
Solvency Due Diligence
Bio-Techne Corp's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Score
Bio-Techne Corp's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
TECH Price Targets Summary
Bio-Techne Corp
According to Wall Street analysts, the average 1-year price target for
TECH
is 82.74 USD
with a low forecast of 51.51 USD and a high forecast of 99.75 USD.
Dividends
Current shareholder yield for TECH is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
TECH
stock under the Base Case scenario is
49.8
USD.
Compared to the current market price of 49.15 USD,
Bio-Techne Corp
is
Undervalued by 1%.